Hemodynamic Forces Regulate Vascular Expression of BMP2/4 and BMP Antagonists
Our understanding of the factors that regulate vascular BMP2/4 expression also suggests a proatherogenic pathophysiological role for BMPs. It has been established that vascular inflammation and atherosclerosis develop in hemodynamically well-defined regions. During normal vascular homeostasis, laminar shear stress maintains an antiinflammatory, antiatherogenic phenotype of endothelial cells. In contrast, adverse changes in the hemodynamic environment, particularly a combination of low shear stress and increased wall tension (eg, resulting from high pressure), elicit proinflammatory phenotypic changes favoring atherogenesis. It is significant that expression of BMP2/4 is regulated by hemodynamic forces (Figure, C) . In a series of elegant studies, Jo's laboratory has demonstrated that expression of BMP4 in cultured endothelial cells is suppressed by initiation of laminar flow. 1, 5, 6, 13 We have recently shown that laminar shear stress regulates BMP4 (but not BMP2) expression both in cultured arteries in vitro and in animal models of increased shear stress in vivo. 2 The transcriptional mechanisms by which shear stress regulates BMP4 expression are not completely understood and may include the cAMP/PKA pathway 2 and mitogen-activated protein kinase signaling. 18, 19 In contrast to atheroprotective laminar shear stress, proatherogenic oscillatory shear stress upregulates BMP4 in endothelial cells. 5, 6, 13 Previous studies have demonstrated that autocrine effects of BMP4 are responsible for the increased adhesiveness of activated monocytes to endothelial cells exposed to oscillatory shear stress. 5, 6 Expression of BMP2 is unaltered by shear stress 2 but can be upregulated by cellular stretch in arteries exposed to high pressure. 4 In coronary arterial endothelial cells, expression of BMP2 also is upregulated by proinflammatory stimuli such as tumor necrosis factor-␣. 3, 4 Surprisingly, BMP4 does not seem to be readily induced by these stimuli. 3 BMPs are produced from inactive precursors that are proteolytically cleaved. Then, the active ligand is secreted into the extracellular space. Binding of BMPs to their cognate receptors leads to phosphorylation of Smad proteins and activation of non-Smad-dependent intracellular signaltransducing pathways (eg, ERK1/2). 3 Smad proteins form hetero-oligomers, translocate to the nucleus, and modulate transcription of target genes. Abundant data show that the BMP signal transduction cascade can be modulated at every
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From It is clear from the study of Chang et al 1 that the BMP antagonists follistatin, noggin, and matrix Gla protein are expressed in cultured endothelial cells. In setting out to prove that expression of BMP antagonists is regulated by shear stress, which they successfully did, the authors also turned up a number of unexpected observations. Contrary to their prediction, Chang et al 1 report that oscillatory shear stress increased, whereas unidirectional laminar shear decreased, the expression of the BMP antagonists in endothelial cells. Of particular interest is that knockdown of the BMP antagonists noggin plus follistatin significantly increased monocyte adhesiveness to endothelial cells exposed to oscillatory shear stress. The results that treatment with recombinant follistatin and/noggin also decreased monocyte adhesion to a similar degree in both oscillatory shear-exposed and static cells are in complete agreement with this view. These findings suggest that coexpression of BMP4 and BMP antagonists may play a negative feedback role against the inflammatory response of BMP4 in atheroprone regions (Figure, C) . The proposed model also predicts that the balance between BMP4 and BMP antagonists may change in pathophysiological conditions associated with an increased risk for atherosclerosis, favoring more proinflammatory BMP4 actions. An unexpected observation from this study is that knockdown of the BMP antagonists significantly increases monocyte adhesiveness to static endothelial cells as well. This interesting finding should provide a basis for further research into the role of BMP antagonists at various levels of shear stress. In addition, the mechanosensitive signaling pathways, which regulate the expression of BMP antagonists, need to be elucidated. Do similar pathways regulate the expression of BMP4 and its antagonists? What is the role of reactive oxygen species in the proposed negative feedback loops? Further studies also are needed to elucidate the role of other hemodynamic forces in controlling the expression of BMP antagonists (eg, high intraluminal pressure, increased wall tension, and/or increased pulse pressure). Chang et al 1 convincingly showed that the expression pattern of BMP antagonists in the mouse aorta is consistent with the in vitro findings: Only endothelial cells in the lesser curvature exposed to disturbed flow, but not those in the greater curvature and straight arterial regions exposed to undisturbed flow, showed coexpression of BMP4 and the BMP antagonists. It will be of great interest to determine whether these new findings apply to other vascular beds (eg, whether other parts of the vascular tree show different expression pattern for BMP antagonists). Studies using various in vivo models of altered shear stress (eg, arteriovenous fistula models 20 ) also would provide additional information about the in vivo coordinated regulation of BMPs and BMP antagonists. It will be equally interesting to address whether, in addition to its proposed role in conduit arteries, mechanosensitive regulation of BMPs and BMP antagonists A, BMP4 elicits endothelial dysfunction by activating NAD(P)H oxidase in mouse carotid arteries. Arterial segments were maintained in vessel culture (for 24 hours) in the absence and presence of recombinant BMP4 (0.1, 1, 4, or 10 ng/mL) as described. 3 Arterial ring preparations were contracted by phenylephrine (10 Ϫ6 mol/L), and relaxations to acetylcholine were obtained 3 can play a role in microvascular remodeling. Chang et al 1 reported that in human coronary arteries, endothelial expression of BMP antagonists (similar to that of BMP4) positively correlated with the severity of atherosclerosis. Although it is tempting to speculate that upregulation of BMP4 and BMP antagonists during plaque development is due to the disturbed flow conditions in the diseased vascular segments, one cannot exclude the possibility that other atherogenic factors (eg, inflammatory stimuli, altered arachidonic acid metabolism) may play a role in this phenomenon. Finally, studies like those of Chang et al 1 are extremely important because they identify novel pathways that could be targeted to attenuate vascular inflammation during the early phases of atherogenesis.
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